Director Renee Tannenbaum Sells 2,000 Shares of ANI Pharmaceuticals Inc (ANIP)
Here's Why Incyte (INCY) Stock is Up More Than 7% in a Week
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)
Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)
Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Merck Ends Keytruda Combo Melanoma Study Due to Futility
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.